WILMINGTON – Delaware BioScience Association has named Michael Fleming as its next president, succeeding Helen Stimson who left the organization this month for a role at Adesis Inc. Delaware Bio represents 130 pharmaceutical and biotechnology ...
WILMINGTON – The Delaware Bioscience Association announced Thursday that its president and CEO, Helen Stimson, was departing June 1 in order to take the role of chief operating officer at Adesis Inc., a contract research ...
Demands on startup companies, especially those with outside investors, can be overwhelming. How can the company’s cash burn be reduced to make financial resources stretch out for as many months or years as possible until ...
Delaware has a lot to celebrate when it comes to the burgeoning biotechnology sector. In the pages ahead, you’ll read about an expansion at the Delaware Innovation Space that will accommodate more small, innovative firms, ...
Over the past five years, the bioscience industry in Delaware has undergone significant changes that were both negative and positive. Earlier this decade we lost about 12% of our jobs due to business decisions by ...